Variant-specific interactions at the plasma membrane: heparan sulfate’s impact on SARS-CoV-2 binding kineticsVisa övriga samt affilieringar
2025 (Engelska)Ingår i: Analytical Chemistry, ISSN 0003-2700, E-ISSN 1520-6882, Vol. 97, nr 8, s. 4318-4328Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
The spread of SARS-CoV-2 led to the emergence of several variants of concern (VOCs). The spike glycoprotein, responsible for engaging the viral receptor, exhibits the highest density of mutations, suggesting an ongoing evolution to optimize viral entry. This study characterizes the bond formed by virion mimics carrying the SARS-CoV-2 spike protein and the plasma membrane of host cells in the early stages of virus entry. Contrary to the traditional analysis of isolated ligand-receptor pairs, we utilized well-defined biomimetic models and biochemical and biophysical techniques to characterize the multivalent interaction of VOCs with the complex cell membrane. We observed an overall increase in the binding affinity for newer VOCs. By progressively reducing the system complexity, we identify heparan sulfate (HS) as a main driver of this variation, with a 10-fold increase in affinity for Omicron BA.1 over that of the original strain. These results demonstrate the essential role of coreceptors, particularly HS, in the modulation of SARS-CoV-2 infection and highlight the importance of multiscale biophysical and biochemical assays that account for membrane complexity to fully characterize and understand the role of molecular components and their synergy in viral attachment and entry.
Ort, förlag, år, upplaga, sidor
American Chemical Society (ACS), 2025. Vol. 97, nr 8, s. 4318-4328
Nationell ämneskategori
Medicinsk bioteknologi (Inriktn. mot cellbiologi (inkl. stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)
Identifikatorer
URN: urn:nbn:se:umu:diva-235998DOI: 10.1021/acs.analchem.4c04283ISI: 001426979700001PubMedID: 39976108Scopus ID: 2-s2.0-86000386504OAI: oai:DiVA.org:umu-235998DiVA, id: diva2:1945191
Forskningsfinansiär
KempestiftelsernaKnut och Alice Wallenbergs StiftelseVetenskapsrådet, 2017-04029Vetenskapsrådet, 2020-06242EU, Horisont 2020, 1010279872025-03-182025-03-182025-03-28Bibliografiskt granskad